Evaluation of seaFAST, a rapid fluorescent in situ hybridization test, for detection of Helicobacter pylori and resistance to clarithromycin in paraffin-embedded biopsy sections

Journal of Clinical Microbiology

Volumn 43, Issue 7, 2005, Pages 3494-3496

  Morris, Julie M ^a   Reasonover, Alisa L ^a   Bruce, Michael G ^a   Bruden, Dana L ^a   McMahon, Brian J ^a,b   Sacco, Frank D ^b   Berg, Douglas E ^c   Parkinson, Alan J ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b ALASKA NATIVE TRIBAL HEALTH CONSORTIUM   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; ANTIBIOTIC AGENT; CLARITHROMYCIN; PARAFFIN; RNA 16S; RNA 23S; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; CHRONIC GASTRITIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; EMBEDDING; FLUORESCENCE IN SITU HYBRIDIZATION; GASTRITIS; HELICOBACTER PYLORI; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PEPTIC ULCER; POINT MUTATION; PRIORITY JOURNAL; STOMACH BIOPSY; STOMACH MUCOSA;

ANTI-BACTERIAL AGENTS; BIOPSY; CLARITHROMYCIN; CULTURE MEDIA; DRUG RESISTANCE, BACTERIAL; FLUORESCENT DYES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MICROBIAL SENSITIVITY TESTS; PARAFFIN EMBEDDING; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; STOMACH; TIME FACTORS;

HELICOBACTER PYLORI;

EID: 22144451127     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.7.3494-3496.2005     Document Type: Article

References (15)

1. Best, L. M., D. J. M. Haldane, M. Keelan, D. E. Taylor, A. B. R. Thomson, V. Loo, C. A. Fallone, P. Lyn, F. M. Smaill, R. Hunt, C. Gaudreau, J. Kennedy, M. Alfa, R. Pelletier, and S. J. O. Veldhuyzen van Zanten. 2003. Multilaboratory comparison of proficiencies in susceptibility testing of Helicobacter pylori and correlation between agar dilution and E test methods. Antimicrob. Agents Chemother. 47:3138-3144.
2. Dailidiene, D., M. T. Bertoli, J. Miciuleviciene, A. K. Mukhopadhyay, G. Dailide, M. A. Pascasio, L. Kupcinskas, and D. E. Berg. 2002. Emergence of tetracycline resistance in Helicobacter pylori: multiple mutational changes in 16S ribosomal DNA and other genetic loci. Antimicrob. Agents Chemother. 46:3940-3946.
3. Graham, D. Y. 1998. Antibiotic resistance in Helicobacter pylori: implications for therapy. Gastroenterology 115:1272-1277.
4. Jüttner, S., M. Vieth, S. Miehlke, W. Schneider-Brachert, C. Kirsch, T. Pfeuffer, N. Lehn, and M. Stolte. 2004. Reliable detection of macrolide-resistant Helicobacter pylori via fluorescence in situ hybridization in formalin-fixed tissue. Mod. Pathol. 17:684-689.
5. Kim, J. J., J. G. Kim, and D. H. Kwon. 2003. Mixed-infection of antibiotic susceptible and resistant Helicobacter pylon isolates in a single patient and underestimation of antimicrobial susceptibility testing. Helicobacter 8:202-206.
6. Lamarque, D., and R. Peek, Jr. 2003. Pathogenesis of Helicobacter pylori infection. Helicobacter 8:21-30.
7. Masuda, H., T. Hiyama, M. Yoshihara, S. Tanaka, F. Shimamoto, K. Haruma, and K. Chayama. 2003. Necessity of multiple gastric biopsies from different sites for detection of clarithromycin-resistant Helicobacter pylori strains. Scand. J. Gastroenterol. 9:942-946.
8. McMahon, B. J., T. Hennessy, J. Bensler, D. Bruden, A. Parkinson, J. Morris, A. Reasonover, D. Hurlburt, M. Bruce, F. Sacco, and J. Butler. 2003. The relationship among previous antimicrobial use, antimicrobial resistance, and treatment outcomes for Helicobacter pylori infections. Ann. Intern. Med. 139:463-469.
9. National Committee for Clinical Laboratory Standards. 2002. Performance standards for antimicrobial susceptibility testing and approved standard M7-A5. Informational supplement M100-S12. National Committee for Clinical Laboratory Standards, Wayne, Pa.
10. Osato, M. S., R. Reddy, S. G. Reddy, R. L. Penland, H. M. Malaty, and D. Y. Graham. 2001. Pattern of primary resistance of Helicobacter pylori to metronidazole and clarithromycin in the United States. Arch. Intern. Med. 161:1217-1220.
11. Piccolomini, R., G. Di Bonaventrua, D. Festi, G. Catamo, F. Laterza, and M. Neri. 1997. Optimal combination of media for primary isolation of Helicobacter pylori from gastric biopsy specimens. J. Clin. Microbiol. 35:1541-1544.
12. Riberio, M. L., M. M. Gerrits, Y. H. B. Benvengo, M. Berning, A. P. O. Godoy, E. J. Kuipers, S. Mendonca, A. H. M. van Vliet, J. Pedrazzoli, Jr., and J. G. Kusters. 2003. Detection of high-level tetracydine resistance in clinical isolates of Helicobacter pylon using PCR-RFLP. FEMS Immunol. Med. Microbiol. 40:57-61.
13. Rüssmann, H., K. Adler, R. Haas, B. Gebert, S. Koletzko, and J. Heesemann. 2001. Rapid and accurate determination of genotypic clarithromycin resistance in cultured Helicobacter pylori by fluorescent in situ hybridization. J. Clin. Microbiol. 39:4142-4144.
14. Rüssmann, H., V. A. J. Kempf, S. Koletzko, J. Heesemann, and I. B. Autenrieth. 2001. Comparison of fluorescent in situ hybridization and conventional culturing for detection of Helicobacter pylori in gastric biopsy specimens. J. Clin. Microbiol. 39:304-308.
15. Trebesius, K., K. Panthel, S. Strobel, K. Vogt, G. Faller, T. Kirchner, M. Kist, J. Heesemann, and R. Haas. 2000. Rapid and specific detection of Helicobacter pylori macrolide resistance in gastric tissue by fluorescent in situ hybridization. Gut 46:608-614.